EN

Beyond mutations.

Towards functional precision.


Unlocking therapeutic targets with patient-derived organoids and high-throughput functional genomics.

Double Honors! Nanjing Zewei Biotech's Organoid Technology Earns Industry Recognition.

 

In March 2025, the 5th Organoid Congress — themed "Organoids and Innovative Drug Discovery & Development“ — was grandly held in Shanghai. Nanjing Zewei Biotechnology Co., Ltd. stood out in the selection process with its groundbreaking innovations in organoid technology, clinching two distinguished honors: the "Technology Breakthrough Award" and the "Best Popularity  Award”.